INS and type 2 diabetes mellitus: This study demonstrates (schematic in Figure 11) that NPC86, a small-molecule therapeutic compound, increases gas5 levels, enhances insulin signaling and metabolic function in DIOD mice, highlighting the therapeutic potential of lncRNA-targeting strategies in T2D.